Advertisement

Determinants of the 25-Hydroxyvitamin D Response to Vitamin D Supplements

  • Bess Dawson-HughesEmail author
Chapter
  • 1.5k Downloads

Abstract

Supplemental vitamin D is now widely recommended, but little guidance is provided on how or when to take vitamin D supplements. The process of vitamin D replacement is complicated by the fact that the increment in 25-hydroxyvitamin D (25OHD) in response to a given dose varies greatly from person to person. This chapter will examine the factors associated with the 25OHD response to supplementation with vitamin D, including genetic determinants, the starting 25OHD level, body mass index, and gastric acid production. It will also consider the effects of a meal and of meal composition with respect to cholesterol and phytosterol intake and the amount and type of dietary fat on the 25OHD response to supplementation.

Keywords

25-Hydroxyvitamin D Vitamin D absorption Genetics Dietary fat MUFA PUFA 

References

  1. 1.
    Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr. 2008;88:1519–27.PubMedCrossRefGoogle Scholar
  2. 2.
    Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21:1151–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF, D’Agostino Sr RB, Ordovas JM, O’Donnell CJ, Dawson-Hughes B, Vasan RS, Booth SL. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2009;63:458–64.PubMedCrossRefGoogle Scholar
  5. 5.
    Wjst M, Altmuller J, Braig C, Bahnweg M, Andre E. A genome-wide linkage scan for 25-OH-D(3) and 1,25-(OH)2-D3 serum levels in asthma families. J Steroid Biochem Mol Biol. 2007;103:799–802.PubMedCrossRefGoogle Scholar
  6. 6.
    Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006;372:33–42.PubMedCrossRefGoogle Scholar
  7. 7.
    Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, Nexo E. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int. 2005;77:15–22.PubMedCrossRefGoogle Scholar
  8. 8.
    Kawakami M, Blum CB, Ramakrishnan R, Dell RB, Goodman DS. Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects. J Clin Endocrinol Metab. 1981;53:1110–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Bu FX, Armas L, Lappe J, Zhou Y, Gao G, Wang HW, Recker R, Zhao LJ. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet. 2010;128:549–56.PubMedCrossRefGoogle Scholar
  10. 10.
    Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem. 2003;278:38084–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem. 2009;42:1174–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Kamboh MI, Ferrell RE. Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum Genet. 1986;72:281–93.PubMedCrossRefGoogle Scholar
  14. 14.
    Signorello LB, Shi J, Cai Q, Zheng W, Williams SM, Long J, Cohen SS, Li G, Hollis BW, Smith JR, Blot WJ. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D levels among African Americans. PLoS One. 2011;6:e28623.PubMedCrossRefGoogle Scholar
  15. 15.
    Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW, Norris JM. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008;93:3381–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Barger-Lux MJ, Heaney RP, Dowell S, Holick MF. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. 1998;8:222–30.PubMedCrossRefGoogle Scholar
  17. 17.
    Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005;97:13–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Gallagher JC, Sai A, Templin 2nd T, Smith L. Dose response to vitamin d supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012;156:425–37.PubMedGoogle Scholar
  19. 19.
    Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–3.PubMedGoogle Scholar
  20. 20.
    Blum M, Dallal GE, Dawson-Hughes B. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr. 2008;27:274–9.PubMedGoogle Scholar
  21. 21.
    Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity. 2012. doi: 10.1038/oby.2011.404.
  22. 22.
    Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, Saltzman E, Dawson-Hughes B. Vitamin D(3) in fat tissue. Endocrine. 2008;33:90–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Wagner D, Hanwell HE, Schnabl K, Yazdanpanah M, Kimball S, Fu L, Sidhom G, Rousseau D, Cole DE, Vieth R. The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation. J Steroid Biochem Mol Biol. 2011;126:72–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Hollander D, Muralidhara KS, Zimmerman A. Vitamin D-3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption. Gut. 1978;19:267–72.PubMedCrossRefGoogle Scholar
  25. 25.
    Reboul E, Goncalves A, Comera C, Bott R, Nowicki M, Landrier JF, Jourdheuil-Rahmani D, Dufour C, Collet X, Borel P. Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res. 2011;55:691–702.PubMedCrossRefGoogle Scholar
  26. 26.
    Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. 1985;42:644–9.PubMedGoogle Scholar
  27. 27.
    Rasmussen L, Oster-Jorgensen E, Qvist N, Hovendal CP, Kraglund K, Olsen O, de Muckadell OB S, Rehfeld J, Pedersen SA. The effects of omeprazole on interdigestive motility and early postprandial levels of gastrin and secretin. Scand J Gastroenterol. 1992;27:119–23.PubMedCrossRefGoogle Scholar
  28. 28.
    Rasmussen L, Qvist N, Oster-Jorgensen E, Rehfeld JF, Holst JJ, Pedersen SA. A double-blind placebo-controlled study on the effects of omeprazole on gut hormone secretion and gastric emptying rate. Scand J Gastroenterol. 1997;32:900–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965;6:506–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Masclee AA, Jansen JB, Driessen WM, Geuskens LM, Lamers CB. Effect of truncal vagotomy on cholecystokinin release, gallbladder contraction, and gallbladder sensitivity to cholecystokinin in humans. Gastroenterology. 1990;98:1338–44.PubMedGoogle Scholar
  31. 31.
    Goncalves A, Gleize B, Bott R, Nowicki M, Amiot MJ, Lairon D, Borel P, Reboul E. Phytosterols can impair vitamin D intestinal absorption in vitro and in mice. Mol Nutr Food Res. 2011;55 Suppl 2:S303–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Grossmann RE, Tangpricha V. Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol Nutr Food Res. 2010;54:1055–61.PubMedGoogle Scholar
  33. 33.
    Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr. 2003;77:1478–83.PubMedGoogle Scholar
  34. 34.
    Mulligan GB, Licata A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010;25:928–30.PubMedCrossRefGoogle Scholar
  35. 35.
    Holvik K, Madar AA, Meyer HE, Lofthus CM, Stene LC. A randomised comparison of increase in serum 25-hydroxyvitamin D concentration after 4 weeks of daily oral intake of 10 microg cholecalciferol from multivitamin tablets or fish oil capsules in healthy young adults. Br J Nutr. 2007;98:620–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud Z, El-Hajj Fuleihan G. Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. J Clin Endocrinol Metab. 2008;93:2693–701.PubMedCrossRefGoogle Scholar
  37. 37.
    Raimundo FV, Faulhaber GA, Menegatti PK, Marques Lda S, Furlanetto TW. Effect of high- versus Low-Fat meal on serum 25-hydroxyvitamin D levels after a single oral dose of vitamin D: a single-blind, parallel, randomized trial. Int J Endocrinol. 2011;2011:809069.PubMedGoogle Scholar
  38. 38.
    Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387–91.PubMedCrossRefGoogle Scholar
  39. 39.
    Hollander D. Intestinal absorption of vitamins A, E, D, and K. J Lab Clin Med. 1981;97:449–62.PubMedGoogle Scholar
  40. 40.
    Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Niramitmahapanya S, Harris SS, Dawson-Hughes B. Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation. J Clin Endocrinol Metab. 2011;96:3170–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Jean Mayer USDA Human Nutrition Research Center on AgingTufts UniversityBostonUSA

Personalised recommendations